1) thyroid-stimulating
甲状腺刺激
1.
Association of thyroid-stimulating antibody with the clinical characteristics of Graves ophthalmopathy;
甲状腺刺激抗体与Graves眼病临床特点的关系
2) thyroid stimulating
甲状腺刺激
1.
Serum thyroid stimulating antibodies(TSAb) before operation were measured with human embro-kidney cells expressing the recombinan.
用表达重组促甲状腺激素 (TSH)受体的人胚肾细胞检测术前血清中的甲状腺刺激性抗体(TSAb)。
2.
The cultured FRTL 5 cells loaded with Ca 2+ probe Fluo 3 were stimulated with different concentrations of TSAb (thyroid stimulating antibody) positive or negative Graves′ IgGs and control IgGs respectively.
为研究初发未治的Graves病患者血清IgG对大鼠甲状腺细胞 (FRTL 5 )内Ca2 + 的作用 ,将Graves病患者血清IgG分为甲状腺刺激抗体 (TSAb)阴性和阳性两组 ,比较正常人、TSAb阴性和阳性IgG对FRTL 5细胞内Ca2 + 的作用。
3) thyroid-stimulating antibodies
甲状腺刺激抗体
1.
Objective To evaluate the effect of orbital radiotherapy on Graves ophthalmopathy and its relations with the serum level of thyroid-stimulating antibodies(TSAb).
目的评价眼球后眶内软组织外照射对甲亢性突眼的疗效以及患者血清中甲状腺刺激抗体(TSAb)与放疗疗效的关系。
4) thyroid stimulating hormone receptor
甲状腺刺激激素受体
1.
Cloning of human thyroid stimulating hormone receptor gene and construction of its eukaryotic expression vector;
人甲状腺刺激激素受体cDNA的克隆及真核表达载体的构建
5) Thyroid stimulating immunoglobulin
甲状腺刺激抗体(TSI)
6) thyroid stimulating antibody
甲状腺刺激性抗体
1.
Objective To observe the effect of thyroid stimulating antibody(TSAb) on the growth and proliferation in thyrocytes and MAPK signal transduction pathway; to probe into the mechanism of TSAb stimulating proliferation of thyrocytes; and elucidate the preliminary molecular mechanism of TSAb leading to the goitor and Graves disease(GD).
目的：观察甲状腺刺激性抗体(TSAb)对甲状腺细胞生长、增殖及MAPK信号传导通路的影响，探讨TSAb引起甲状腺细胞增殖的机制，以初步阐明TSAb引起甲状腺肿大致Graves 病(GD)发病的分子机制。
补充资料：长效甲状腺刺激素
长效甲状腺刺激素
是1956年在突眼性甲状腺功能亢进患者血浆中发现的一种蛋白质。它的发现推翻了长期认为促甲状腺素分泌过多，引起甲腺功能亢进的学说。LATS是针对甲状腺细胞表面TSH受体的自身抗体IgG，能刺激甲状腺细胞合成和释放过多的甲状腺素导致甲亢。由于它的作用缓慢而持久，故称为长效甲状腺刺激素。甲亢病人阳性率达50%，尤其突眼者。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条